发明名称 |
TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |
摘要 |
<p>The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR-mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti-EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.</p> |
申请公布号 |
EP2134854(B1) |
申请公布日期 |
2015.04.15 |
申请号 |
EP20080726810 |
申请日期 |
2008.03.14 |
申请人 |
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. |
发明人 |
CAVENEE, WEBSTER;FURNARI, FRANK;JOHNS, TERRANCE, GRANT;SCOTT, ANDREW |
分类号 |
C12P21/08;A61K39/395;A61P35/00;C07K16/28;C07K16/30 |
主分类号 |
C12P21/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|